| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |